价格

Bayer Vital GmbH

ACTIVE

Kaiser-Wilhelm-Allee 70, Leverkusen, Nordrhein-Westfalen, 德国www.bayervital.deSubsidiary

别名:

bv-ph-med-msl/ außenstelle nord

gb pflanzenschutz reg. ost

gb pflanzenschutz

gb diagnostics

bayer vital gmbh diagnostic

隶属于 BAYER AG

概览

试验阶段分布

暂无试验阶段数据

试验状态分布

进行中（未招募）

100.0%

药物批准

按机构分类的批准

NMPA

National Medical Products Administration

药物批准

近期批准

Gadoxetic Acid Disodium Injection

NMPA

2024-01-15

Gadoxetic Acid Disodium Injection

NMPA

2024-01-15

Moxifloxacin Hydrochloride and Sodium Chloride Injection

NMPA

2023-09-22

Moxifloxacin Hydrochloride and Sodium Chloride Injection

NMPA

2023-09-22

Moxifloxacin Hydrochloride Tablets

NMPA

2023-06-07

Moxifloxacin Hydrochloride Tablets

NMPA

2023-06-07

Moxifloxacin Hydrochloride Tablets

资讯

暂无资讯文章

返回机构列表

Bayer Vital GmbH

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（3）

A randomized, double-blind, single centre, placebo-controlled pilot study to assess on a molecular level the influence of a 5 % dexpanthenol ointment in subjects with previously injured skin by investigation of skin biopsies

A randomized, double-blind, parallel group prospective pilot study to assess the effect of vardenafil on clinical outcome and on procedure duration after green light laser-ablation of the prostate gland for therapy of benign prostate hypertrophy (BPH)

A 4-week, open-label, multicenter, urodynamic pilot study to explore the efficacy, tolerability and safety of darifenacin (7.5 mg with up-titration to 15 mg) in patients with multiple sclerosis and neurogenic detrusor overactivity

药物批准

按机构分类的批准

近期批准

资讯